134 related articles for article (PubMed ID: 31638449)
1. Is ultra wide-field retinal imaging alone appropriate for retinal angioma screening in lower risk subjects attending Von Hippel-Lindau (VHL) clinics?
Mansfield Smith S; Makam R; Sullivan L; Sandford R; Allen L
Ophthalmic Genet; 2019 Oct; 40(5):403-406. PubMed ID: 31638449
[No Abstract] [Full Text] [Related]
2. Retinal angiomatosis and von Hippel-Lindau disease.
Kreusel KM; Bechrakis NE; Heinichen T; Neumann L; Neumann HP; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 2000 Nov; 238(11):916-21. PubMed ID: 11148816
[TBL] [Abstract][Full Text] [Related]
3. The eye in von Hippel-Lindau disease. Long-term follow-up of screening and treatment: recommendations.
Wittebol-Post D; Hes FJ; Lips CJ
J Intern Med; 1998 Jun; 243(6):555-61. PubMed ID: 9681858
[TBL] [Abstract][Full Text] [Related]
4. Solitary juxtapapillary capillary retinal angioma and von Hippel-Lindau disease.
Kreusel KM; Bechrakis NE; Neumann HP; Schmidt D; Foerster MH
Can J Ophthalmol; 2007 Apr; 42(2):251-5. PubMed ID: 17392848
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
Webster AR; Maher ER; Moore AT
Arch Ophthalmol; 1999 Mar; 117(3):371-8. PubMed ID: 10088816
[TBL] [Abstract][Full Text] [Related]
6. Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study.
Kreusel KM; Bechrakis NE; Krause L; Neumann HP; Foerster MH
Ophthalmology; 2006 Aug; 113(8):1418-24. PubMed ID: 16769118
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.
Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM
Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017
[TBL] [Abstract][Full Text] [Related]
8. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
9. Detection of retinal microvascular changes in von Hippel-Lindau disease using optical coherence tomography angiography.
Lu Y; Wang JC; Zeng R; Nagata T; Katz R; Mukai S; Miller JB
PLoS One; 2020; 15(2):e0229213. PubMed ID: 32078656
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.
Vikkath N; Valiyaveedan S; Nampoothiri S; Radhakrishnan N; Pillai GS; Nair V; Pooleri GK; Mathew G; Menon KN; Ariyannur PS; Pillai AB
Fam Cancer; 2015 Dec; 14(4):585-94. PubMed ID: 25952756
[TBL] [Abstract][Full Text] [Related]
12. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
13. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease.
Niemelä M; Lemeta S; Sainio M; Rauma S; Pukkala E; Kere J; Böhling T; Laatikainen L; Jääskeläinen J; Summanen P
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1909-15. PubMed ID: 10845616
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis.
Wong WT; Agrón E; Coleman HR; Reed GF; Csaky K; Peterson J; Glenn G; Linehan WM; Albert P; Chew EY
Arch Ophthalmol; 2007 Feb; 125(2):239-45. PubMed ID: 17296901
[TBL] [Abstract][Full Text] [Related]
15. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease.
Binderup MLM; Stendell AS; Galanakis M; Møller HU; Kiilgaard JF; Bisgaard ML
Br J Ophthalmol; 2018 Jul; 102(7):942-947. PubMed ID: 28972023
[TBL] [Abstract][Full Text] [Related]
16. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
[TBL] [Abstract][Full Text] [Related]
17. Surveillance in von Hippel-Lindau disease (vHL).
Poulsen ML; Budtz-Jørgensen E; Bisgaard ML
Clin Genet; 2010 Jan; 77(1):49-59. PubMed ID: 19863552
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Audit Comparing Optos Widefield Imaging to Fundus Examination for Von Hippel-Lindau Retinal Screening.
Iqbal N; Stahl M; Lim E; Al-Khuzaei S; Jones R; Halliday D; Downes S
Cureus; 2022 Dec; 14(12):e32814. PubMed ID: 36582420
[TBL] [Abstract][Full Text] [Related]
19. VHL P25L is not a pathogenic von Hippel-Lindau mutation: a family study.
Pettman RK; Crowley A; Riddell C; Ludman MD
Mol Diagn Ther; 2006; 10(4):239-42. PubMed ID: 16884327
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]